You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Exogenous pulmonary surfactant as a carrier of budesonide
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-FDP-023
- By: CIMATO, Alejandra (Universidad de Buenos Aires, Argentina)
- Co-author(s): Alejandra Cimato
Andres Hoyos Obando: Universidad de Buenos Aires, Buenos Aires, Argentina
Graciela Facorro: Universidad de Buenos Aires, Buenos Aires, Argentina
Margarita Martinez Sarrasague: Universidad de Buenos Aires,Buenos Aires,Argentina - Abstract:
Background
Budesonide (Bu) is commonly used to treat chronic lung disease. The incorporation of Bu in the membranes of an exogenous pulmonary surfactant (EPS) could be a novel alternative management to avoid side effects and improve drug delivery. Also, EPS would have therapeutic effect by itself, so it is essential that the presence of Bu does
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026